Stryker Corporation (SYK)

NYSE
Currency in USD
392.20
+5.88(+1.52%)
Closed·
Pre Market
391.11-1.09(-0.28%)
·
SYK Scorecard
Full Analysis
Has raised its dividend for 15 consecutive years
SYK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
384.58392.63
52 wk Range
314.93406.19
Key Statistics
Edit
Prev. Close
392.2
Open
388.5
Day's Range
384.58-392.63
52 wk Range
314.93-406.19
Volume
1.12M
Average Vol. (3m)
1.66M
1-Year Change
18.14%
Book Value / Share
54.84
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SYK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
423.98
Upside
+8.10%
Members' Sentiments
Bearish
Bullish
ProTips
22 analysts have revised their earnings downwards for the upcoming period
Show more

Stryker Corporation Company Profile

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Stryker Corporation SWOT Analysis


Innovation Pipeline
Learn about Stryker's focus on robotics and minimally invasive procedures, driving record adoption and utilization across its product portfolio.
Analyst Optimism
Delve into analyst projections, with an average price target of $433, reflecting confidence in Stryker's growth strategy and market positioning.
Financial Resilience
Explore Stryker's robust financial health, with revenue growth of 10.23% and a gross profit margin of 64.37%, underpinning its market leadership.
VTE Market Expansion
Stryker's acquisition of Inari Medical positions it to capitalize on the $15 billion global VTE market, growing at 20% annually in the U.S.
Read full SWOT analysis

Stryker Corporation Earnings Call Summary for Q1/2025

  • Q1 2025 EPS of $2.84 beat forecasts by 4.8%, with revenue reaching $5.9 billion, surpassing expectations
  • Organic sales growth of 10.1% driven by strong U.S. and international demand; Mako robotic system installations hit record levels
  • Stock dipped 0.8% in after-hours trading despite earnings beat, closing at $371
  • Company maintains full-year organic sales growth guidance of 8.5-9.5% and adjusted EPS of $13.20-$13.45
  • Tariff impact estimated at $200 million for 2025; foreign currency fluctuations and supply chain disruptions pose potential risks
Last Updated: 05/01/2025, 05:44 PM
Read Full Transcript

Compare SYK to Peers and Sector

Metrics to compare
SYK
Peers
Sector
Relationship
P/E Ratio
52.4x−13.9x−0.5x
PEG Ratio
−3.370.000.00
Price / Book
7.2x2.9x2.6x
Price / LTM Sales
6.5x2.0x2.9x
Upside (Analyst Target)
11.3%33.1%45.8%
Fair Value Upside
Unlock9.6%8.6%Unlock

Analyst Ratings

22 Buy
9 Hold
1 Sell
Ratings:
32 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 423.98
(+8.10% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 7.50%
Dividend Yield
0.87%
Industry Median 0.71%
Annualized Payout
3.36
Paid quarterly
5-Years Growth
+8.41%
Growth Streak

Earnings

Latest Release
May 01, 2025
EPS / Forecast
2.84 / 2.71
Revenue / Forecast
5.90B / 5.68B
EPS Revisions
Last 90 days

People Also Watch

511.99
IDXX
+0.50%
104.86
BSX
+1.86%
385.50
HCA
+4.90%
285.97
COR
+2.44%
172.27
BDX
+0.73%

FAQ

What Is the Stryker (SYK) Stock Price Today?

The Stryker stock price today is 392.20

What Stock Exchange Does Stryker Trade On?

Stryker is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Stryker?

The stock symbol for Stryker is "SYK."

Does Stryker Pay Dividends? What’s The Current Dividend Yield?

The Stryker dividend yield is 0.86%.

What Is the Stryker Market Cap?

As of today, Stryker market cap is 149.89B.

What Is Stryker's Earnings Per Share (TTM)?

The Stryker EPS (TTM) is 7.50.

When Is the Next Stryker Earnings Date?

Stryker will release its next earnings report on Jul 31, 2025.

From a Technical Analysis Perspective, Is SYK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.